This content is not meant to replace a conversation with a healthcare provider. A healthcare provider can evaluate your symptoms and make appropriate clinical decisions.
This content is not meant to replace a conversation with a healthcare provider. A healthcare provider can evaluate your symptoms and make appropriate clinical decisions.

Don’t miss what’s next in HAE

Access the latest content

DISCOVER A WORLD OF RESOURCES FOR YOU AND PEOPLE WITH HAE

HAE GLOSSARY

There are many words or phrases that come with an HAE diagnosis. This glossary can help you learn some key terms to help you better understand HAE and its management.

Abdominal attack

An HAE attack that causes swelling in the intestinal wall and can cause stomach pain, nausea, vomiting, and/or diarrhea.

Bradykinin

A natural substance found in the blood. If there is too much bradykinin in a person’s blood, it may result in the swelling experienced during an HAE attack.

C1 inhibitor

A protein in your blood that helps to control swelling in the body. Without enough C1 inhibitor, your body can’t control swelling properly.

Laryngeal attack

This type of HAE attack happens when the major airway in the throat swells up. This type of attack can be life-threatening if not treated as soon as possible.

Subcutaneous attack

A type of HAE attack that affects the skin, typically on the hands, feet, face, or genitals.

Triggers

Something that sets off an HAE attack. Some common triggers are stress, excitement, infections, trauma, a medical procedure, hormone changes, and certain drugs. HAE attacks can also happen without any known triggers.

Warning signs

Before an attack begins, some people with HAE experience warning signs, such as mood changes, anxiety, fatigue, nausea, rash, or a tingling feeling.

Red winged background

Today’s HAE management may be forcing people to choose among efficacy, tolerability, and convenience

Understand the trade-offs

References

  1. Abdulkarim A, et al. Hereditary angioedema. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. https://www.ncbi.nlm.nih.gov/books/NBK482266/
  2. Anderson J, et al. Allergy Asthma Clin Immunol. 2021;17(1):60.
  3. Angioedema Centers of Reference and Excellence. Who we are. Accessed May 23, 2024. https://acare-network.com
  4. Aygören-Pürsün E, et al. Allergy. 2013;68(8):1034-1039.
  5. Aygören-Pürsün E, et al. Orphanet J Rare Dis. 2014;9(99):1-9.
  6. Azmy V, et al. Allergy Asthma Proc. 2020;41(Suppl 1):S18-S21.
  7. Banerji A, et al. Allergy Asthma Proc. 2015;36:213-217.
  8. Banerji A, et al. Ann Allergy Asthma Immunol. 2020;124:600-607.
  9. Betschel SD, et al. J Allergy Clin Immunol Pract. 2023;11(8):2315-2325.
  10. Betschel SD, et al. Allergy Asthma Clin Immunol. 2024;20(43):1-8.
  11. Betschel SD, et al. Allergy Asthma Clin Immunol. 2025;21(25):1-11.
  12. Broderick L, et al. Orphanet J Rare Dis. 2025;20(16):1-11.
  13. Busse PJ, et al. N Engl J Med. 2020;382:1136-1148.
  14. Busse PJ, et al. J Allergy Clin Immunol Pract. 2021;9(1):132-150.
  15. Castaldo AJ, et al. Ann Allergy Asthma Immunol. 2025 May 23:S1081-1206(25)00258-3.
  16. Chong-Neto HJ. World Allergy Organ J. 2023;16(3):100758.
  17. Covella B, et al. Future Pharmacol. 2024;4(1):41-53.
  18. Data on file, Pharvaris.
  19. Everyday Health. Speaking hereditary angioedema (HAE): a glossary of terms used to describe symptoms, tests, treatments, and more. Accessed May 23, 2025. https://www.everydayhealth.com/hereditary-angioedema/glossary-of-terms-used-to-describe-symptoms-tests-treatments-and-more/
  20. Farkas H, et al. Clin Transl Allergy. 2021;11(4):e12035.
  21. Ferreira G, et al. J Investig Allergol Clin Immunol. 2023;33(5):332-362.
  22. Firazyr [prescribing information]. Shire Human Genetic Therapies, Inc. Accessed June 6, 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022150s016lbl.pdf
  23. Food and Drug Administration. The voice of the patient – hereditary angioedema. Published May 2018. Accessed May 23, 2025. https://www.fda.gov/files/about%20fda/published/The-Voice-of-the-Patient—Hereditary-Angioedema.pdf
  24. Geba D, et al. J Drug Assess. 2021;10(1):51-56.
  25. Gülbahar O. Balkan Med J. 2021;38(2):73-81.
  26. Haegarda [prescribing information]. CSL Behring GmbH. Accessed June 6, 2025. https://www.fda.gov/media/105611/download
  27. Hereditary Angioedema Canada. Learning to live with hereditary angioedema. Accessed May 23, 2025. https://haecanada.org/wp-content/uploads/sites/64/2020/10/HAE-Canada-patient-booklet-Updated-2020-v2.pdf
  28. Hereditary Angioedema International. About HAEi. Accessed May 23, 2025. https://haei.org/about-haei/
  29. Hereditary Angioedema International. Frequently asked questions. Accessed May 23, 2025. https://haei.org/hae/faq/
  30. Hsu FL, et al. Allergy Asthma Clin Immunol. 2022;18(64):1-9.
  31. Jean-Baptiste M, et al. Orphanet J Rare Dis. 2022;17(232):1-12.
  32. Johnston DT, et al. Allergy Asthma Proc. 2020;41:S43-S46.
  33. Leibovich-Nassi I, et al. Clin Rev Allergy Immunol. 2021;61:15-28.
  34. Lima H, et al. Front Allergy. 2023;10(4):1-5.
  35. Lo SH, et al. Pharmacoecon Open. 2022;6(2):231-239.
  36. Longhurst HJ, et al. Br J Hosp Med (Lond). 2019;80(7):391-398.
  37. Lumry WR, et al. Allergy Asthma Proc. 2020;41(Suppl 1):S08-S13.
  38. Manning ME. Allergy Asthma Proc. 2020;41(Suppl 1):S22-S25.
  39. Maurer M, et al. Allergy. 2022;77(7):1961-1990.
  40. Mayo Clinic. Hives and angioedema. Accessed May 23, 2025. https://www.mayoclinic.org/diseases-conditions/hives-and-angioedema/symptoms-causes/syc-20354908
  41. National Organization for Rare Disorders. Hereditary angioedema. Accessed May 23, 2025. https://rarediseases.org/rare-diseases/hereditary-angioedema/
  42. Pagnier A, et al. Pediatr Allergy Immunol. 2024;35:e14268.
  43. Purdue University. College of Science. Career development. Accessed May 23, 2025. https://www.purdue.edu/science/careers/what_can_i_do_with_a_major/Career%20Pages/immunologist.html#:~:text=Immunologists%20are%20research%20scientist
  44. Radojicic C, et al. Allergy Asthma Proc. 2021;42(3):S4-S10.
  45. Riedl MA, et al. Ann Allergy Asthma Immunol. 2017;119(1):59-64.
  46. Riedl MA, et al. Allergy. 2020;75(11):2879-2887.
  47. Riedl MA, et al. Allergy Asthma Proc. 2021;42:S17-S25.
  48. Savarese L, et al. Allergy Asthma Proc. 2021;42(1):e1-e7.
  49. Shamanaev A, et al. Front Physiol. 2023;14:1146834:1-13.
  50. Smith TD, et al. Ann Allergy Asthma Immunol. 2024;133:380-390.
  51. Soteres DF, et al. Clin Case Rep. 2021;9(11):e05086.
  52. Takhzyro [prescribing information]. Dyax Corp. Accessed June 6, 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761090s010lbl.pdf
  53. US Hereditary Angioedema Association. Conquering hereditary angioedema together. Accessed May 23, 2025. https://www.haea.org/
  54. US Hereditary Angioedema Association. About hereditary angioedema. Accessed May 23, 2025. https://www.haea.org/pages/p/what_is_hae#:~:text=Symptoms%3A%20HAE%20Attacks,those%20in%20the%20same%20family%204
  55. US Hereditary Angioedema Association. Treatments. Accessed May 23, 2025. https://www.haea.org/pages/p/treatments
  56. Wedner HJ, et al. J Allergy Clin Immunol Pract. 2021;9(6):2305-2314.e4.
  57. Zacek L. Nursing. 2022;52(12):44-50.
  58. Zanichelli A, et al. Ann Allergy Asthma Immunol. 2016;117:394-398.
  59. Zuraw BL. World Allergy Organ J. 2010;11:S25-S28.
  60. Zuraw BL, et al. Allergy Asthma Proc. 2025;46:209-217.

You are about to leave hcp.deflatehae.com. You are about to leave deflatehae.com.

Click “Yes” to continue. Or, if you’d like to keep browsing hcp.deflateHAE.com, click “No.” Click “Yes” to continue. Or, if you’d like to keep browsing deflateHAE.com, click “No.”

Yes
No

Become a part of the deflate HAE community

Share your information and join the more than 1,200 people who have already
signed up. Get the latest updates on deflate HAE, including community
stories, engaging interactive tools, and valuable resources.

All fields and checkboxes are required.

STAY IN TOUCH > Balloon Badge Speech Badge

© 2025 Pharvaris®. All rights reserved. MAT-US-UN-0092

The terms injection-like efficacy™ and injectable-like efficacy™ are trademarks of Pharvaris.

All trademarks, logos, and brand names are the property of their respective owners.

Emma with balloon

Real person living with HAE.

Don't miss what's next in HAE